Meridian Bioscience Launches New Molecular Test for the Detection of Mycoplasma pneumoniae
27 avr. 2016 07h00 HE
|
Meridian Bioscience Inc.
CINCINNATI, April 27, 2016 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced that it has received the CE Mark for a new molecular diagnostic test for Mycoplasma...